Companies similar to Roivant Sciences (ROIV)
Health Care · NASDAQ
Roivant Sciences (ROIV)'s closest peers include IMMUNOVANT INC (IMVT), ARBUTUS BIOPHARMA CORP (ABUS), Moderna (MRNA), Regeneron Pharmaceuticals (REGN), Amgen (AMGN) and Bristol Myers Squibb (BMY). This peer set is drawn from ROIV's enriched company profile and is informational only — not financial advice.
Similar companies
-
IMMUNOVANT INCIMVTHealth Care
Immunovant is a clinical-stage immunology company developing IMVT-1402, a potentially best-in-class FcRn inhibitor to treat autoimmune diseases driven by…
$39.53 (as of 2026-07-21) · market cap $8.2B
-
ARBUTUS BIOPHARMA CORPABUSHealth Care
A biopharmaceutical company advancing a clinical pipeline to treat chronic hepatitis B while monetizing its intellectual property through strategic licensing…
$4.52 (as of 2026-07-21) · market cap $884M
-
ModernaMRNAHealth Care
Moderna is an unprofitable mRNA vaccine and therapeutic company pivoting from peak COVID revenues with a diversified pipeline facing intense competition and…
$59.66 (as of 2026-07-21) · market cap $23.6B
-
Regeneron PharmaceuticalsREGNHealth Care
Regeneron develops and commercializes monoclonal antibody and other biologics therapies across immunology, oncology, infectious disease, and other therapeutic…
$675.19 (as of 2026-07-21) · market cap $69.9B
-
AmgenAMGNHealth Care
A global biotechnology innovator producing biologics, monoclonal antibodies, and small molecules across oncology, cardiovascular, inflammation, and bone…
$366.24 (as of 2026-07-21) · market cap $195.6B
-
Bristol Myers SquibbBMYHealth Care
Bristol Myers Squibb is a leading biopharmaceutical company specializing in advanced oncology, immunology, and cardiovascular therapies using diverse…
$60.93 (as of 2026-07-21) · market cap $123.2B
Not quite? Describe exactly what you want →
Peers are drawn from ROIV's enriched profile (the same similarity signal the chat uses for "companies like ROIV"). See the full profile: Roivant Sciences (ROIV).
Last updated 2026-07-21.
Informational only — NOT financial advice. Company data is sourced from SEC EDGAR + Finnhub and shown with its as-of date.